Access cutting-edge multiple sclerosis treatment through this clinical trial at a research site in Berkeley. Study-provided care at no cost to qualified participants.
Access multiple sclerosis specialists in Berkeley at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple sclerosis treatment provided free
The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to 36 months double-blind administration of study intervention compared to placebo in male and female participants with nrSPMS (aged 18 to 60 years at the time of enrollment). People diagnosed with nrSPMS are eligible for enrollment as long as they meet all the inclusion criteria and none of the exclusion criter
Sponsor: Sanofi
Check if you qualify for this multiple sclerosis clinical trial in Berkeley, CA
If you're searching for multiple sclerosis treatment options in Berkeley, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Berkeley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.